Improve SCA Bridge Study

NCT ID: NCT03715790

Last Updated: 2024-01-16

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1491 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-02

Study Completion Date

2021-05-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the Improve SCA Bridge study is to characterize the care pathway flow of post-acute myocardial infarction (MI) patients as a result of standard assessments of left ventricular ejection fraction (LVEF) in the acute phase (≤14 days post- acute MI) and chronic phase (≥40-90 days post-acute MI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To determine how many patients are referred for sudden cardiac death (SCD) risk stratification and management, indicated for implantable cardioverter defibrillator (ICD), or cardiac resynchronization therapy- defibrillator (CRT-D) implant, and how many receive such devices within 12 months of experiencing an MI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sudden Cardiac Arrest Acute Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EP Referred Group

Subjects with EF ≤ 40% or meeting one of the referral criteria

EP referred group

Intervention Type BEHAVIORAL

Referred for sudden cardiac death (SCD) risk stratification and management

Non-Referred Group

Subjects with 40%\< EF \<50%.

Non-Referred group

Intervention Type BEHAVIORAL

Not referred for sudden cardiac death (SCD) risk stratification and management.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EP referred group

Referred for sudden cardiac death (SCD) risk stratification and management

Intervention Type BEHAVIORAL

Non-Referred group

Not referred for sudden cardiac death (SCD) risk stratification and management.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 and above (or meet age requirements per local law)
* Patients who have an acute Myocardial Infarction (MI) (STEMI or Non-STEMI) ≤ 30 days of study enrollment and have a LVEF \<50% measurement ≤ 14 days post-acute MI
* Willing and able to give valid Informed Consent

Exclusion Criteria

* Patient has previously received or currently implanted with an ICD or CRT-D
* Patient has any contraindication for ICD/CRT-D
* Patient has a life expectancy of less than 12 months
* Patient who has had an EP referral within the last 12 months
* Patient is unable (e.g. mental disorder) or unwilling to be compliant with the responsibilities as specified in the informed consent form.
* Patient is enrolled in a concurrent study that has not been approved for concurrent enrollment by the Medtronic Clinical Trial Leader
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shu Zhang

Role: PRINCIPAL_INVESTIGATOR

Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Heart Foundation Hospital and Research Institute

Dhaka, , Bangladesh

Site Status

Gleneagles Jerudong Park Medical Centre

Brunei, , Brunei

Site Status

Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, , China

Site Status

Peking University First Hospital

Beijing, , China

Site Status

The Second Xiangya Hospital of Central South University

Changsha, , China

Site Status

West China Hospital of Sichuan University

Chendu, , China

Site Status

Sun Yat-SEN Memorial hospital, Sun Yat-sen University

Guangzhou, , China

Site Status

Guizhou Provincial People's Hospital

Guizhou, , China

Site Status

Hangzhou First People Hospital

Hangzhou, , China

Site Status

Sir Run Run Shaw Hospital School of Medicine Zhejiang University

Hangzhou, , China

Site Status

The first Hospital of Lanzhou Hospital

Lanzhou, , China

Site Status

Nanjing First Hospital

Nanjing, , China

Site Status

Shanghai Chest Hospital

Shanghai, , China

Site Status

Sichuan Provincial People's Hospital

Sichuan, , China

Site Status

Wuhan Asia heart hospital

Wuhan, , China

Site Status

Xiamen Cardiovascular Hospital

Xiamen, , China

Site Status

The First Affiliated Hospital of Xinjiang Medical University

Xinjiang, , China

Site Status

International Cardic Center

Alexandria, , Egypt

Site Status

The Madras Medical Mission

Chennai, , India

Site Status

Eternal Hospital

Jaipur, , India

Site Status

Kasturba Medical College Hospital

Mangalore, , India

Site Status

Batra Hospital and Medical Research Centre (BHMRC)

New Delhi, , India

Site Status

Fortis Escorts Heart Institute

New Delhi, , India

Site Status

National Cardiovascular Center Harapan Kita

Jakarta, , Indonesia

Site Status

Rumah Sakit Cipto Mangunkusumo

Jakarta, , Indonesia

Site Status

Hospital Serdang

Kajang, , Malaysia

Site Status

Queen Elizabeth II Hospital

Kota Kinabalu, , Malaysia

Site Status

Sarawak Heart Centre

Kota Samarahan, , Malaysia

Site Status

National Institute of Cardiovascular Diseases

Karachi, , Pakistan

Site Status

Chinese General Hospital and Medical Center

Manila, , Philippines

Site Status

King Fahad Armed Forces Hospital

Jeddah, , Saudi Arabia

Site Status

Prince Sultan Cardiac Center

Riyadh, , Saudi Arabia

Site Status

Changi General Hospital

Singapore, , Singapore

Site Status

Mediclinic Panorama

Cape Town, , South Africa

Site Status

Netcare Unitas Hospital

Pretoria, , South Africa

Site Status

Chonnam National University Hospital

Gwangju, , South Korea

Site Status

Sejong General Hospital

Gyeonggi-do, , South Korea

Site Status

Pusan National University Yangsan Hospital

Pusan, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Keimyung University Dongsan Medical Center

Seoul, , South Korea

Site Status

Korea University Anam Hospital

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Seoul National University Bundang Hospital

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Kaohsiung Chang Gung Memorial Hospital of CGMF

Kaohsiung City, , Taiwan

Site Status

Far Eastern Memorial Hospital

New Taipei City, , Taiwan

Site Status

China Medical University Hospital

Taichung, , Taiwan

Site Status

Mackay Memorial Hospital

Taipei, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Linkou Chang Gung Memorial Hospital

Taoyuan District, , Taiwan

Site Status

King Chulalongkorn Memorial Hospital

Bangkok, , Thailand

Site Status

The Military Hospital of Tunis

Montfleury, , Tunisia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bangladesh Brunei China Egypt India Indonesia Malaysia Pakistan Philippines Saudi Arabia Singapore South Africa South Korea Taiwan Thailand Tunisia

References

Explore related publications, articles, or registry entries linked to this study.

Chew DS, Wilton SB, Kavanagh K, Southern DA, Tan-Mesiatowsky LE, Exner DV; APPROACH Investigators. Left ventricular ejection fraction reassessment post-myocardial infarction: Current clinical practice and determinants of adverse remodeling. Am Heart J. 2018 Apr;198:91-96. doi: 10.1016/j.ahj.2017.11.014. Epub 2017 Dec 5.

Reference Type RESULT
PMID: 29653653 (View on PubMed)

Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA. 2008 Nov 5;300(17):2022-9. doi: 10.1001/jama.2008.553.

Reference Type RESULT
PMID: 18984889 (View on PubMed)

Chia YMF, Teng TK, Tan ESJ, Tay WT, Richards AM, Chin CWL, Shimizu W, Park SW, Hung CL, Ling LH, Ngarmukos T, Omar R, Siswanto BB, Narasimhan C, Reyes EB, Yu CM, Anand I, MacDonald MR, Yap J, Zhang S, Finkelstein EA, Lam CSP. Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure. Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11):e003651. doi: 10.1161/CIRCOUTCOMES.116.003651.

Reference Type RESULT
PMID: 29150533 (View on PubMed)

O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013 Jul 1;82(1):E1-27. doi: 10.1002/ccd.24776. Epub 2013 Jan 8. No abstract available.

Reference Type RESULT
PMID: 23299937 (View on PubMed)

Zhang S, Chen WJ, Sankardas MA, Ahmed WH, Liew HB, Gwon HC, Nesa Malik FT, Tang B, Haggui A, Oh IY, Ong TK, Cheng CI, Liu X, Seth A, Choi YJ, Qamar N, Rungpradubvong V, Wang CC, Jeon J, Wong G, Lemme F, Van Dorn B, Lexcen D, Huang D; Improve Sudden Cardiac Arrest Bridge Investigators. Improve the Prevention of Sudden Cardiac Arrest in Patients With Post-Acute Myocardial Infarction. JACC Asia. 2022 Sep 20;2(5):559-571. doi: 10.1016/j.jacasi.2022.06.006. eCollection 2022 Oct.

Reference Type DERIVED
PMID: 36518723 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MDT18019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sonothrombolysis in Patients With STEMI
NCT03092089 COMPLETED PHASE2